Atherosclerosis imaging

Canadian Journal of Cardiology

Volumn 21, Issue 12, 2005, Pages 1035-1039

  Tardif, Jean Claude ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Atherosclerosis; Imaging; Intravascular ultrasound; Lipids; Regression

Indexed keywords

AMLODIPINE BESYLATE; ATORVASTATIN; AVASIMIBE; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL ESTER TRANSFER PROTEIN INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ETC 216; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; PLACEBO; PRAVASTATIN; PROBUCOL; PROBUCOL SUCCINATE; TORCETRAPIB;

ANGIOCARDIOGRAPHY; ARTERY WALL; ATHEROSCLEROSIS; CLINICAL STUDY; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DOSE RESPONSE; HEART TRANSPLANTATION; HUMAN; INTRAVASCULAR ULTRASOUND; PATIENT MONITORING; TREATMENT OUTCOME;

CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; EQUIPMENT SAFETY; HUMANS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 28444472702     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (57)

1. Berenson GS, Wattigney WA, Tracy RE, et al. Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study). Am J Cardiol 1992;70:851-8.
2. Tuzcu EM, Kapadia SR, Tutar E, et al. High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: Evidence from intravascular ultrasound. Circulation 2001;103:2705-10.
3. Tardif JC. The future of intravascular ultrasound in the detection and management of coronary artery disease. Can J Cardiol 2000;16(Suppl D):12D-15D.
4. Tardif JC, Pandian NG. Intravascular ultrasound imaging in peripheral arterial and coronary artery disease. Curr Opin Cardiol 1994;9:627-33.
5. Tardif JC, Bertrand OF, Mongrain R, et al. Reliability of mechanical and phased-array designs for serial intravascular ultrasound examinations - animal and clinical studies in stented and non-stented coronary arteries. Int J Card Imaging 2000;16:365-75.
6. Schoenhagen P, Sapp SK, Tuzcu EM, et al. Variability of area measurements obtained with different intravascular ultrasound catheter systems: Impact on clinical trials and a method for accurate calibration. J Am Soc Echocardiogr 2003;16:277-84. (Erratum in 2005;18:193).
7. Rioufol G, Finet G, Ginon I, et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: A three-vessel intravascular ultrasound study. Circulation 2002;106:804-8.
8. Kotani J, Mintz GS, Castagna MT, et al. Intravascular ultrasound analysis of infarct-related and non-infarct-related arteries in patients who presented with an acute myocardial infarction. Circulation 2003;107:2889-93.
9. Porter TR, Sears T, Xie F, et al. Intravascular ultrasound study of angiographically mildly diseased coronary arteries. J Am Coll Cardiol 1993;22:1858-65.
10. Mintz GS, Painter JA, Pichard AD, et al. Atherosclerosis in angiographically "normal" coronary artery reference segments: An intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 1995;25:1479-85.
11. Schoenhagen P, Nissen SE, Tuzcu EM. Coronary arterial remodeling: From bench to bedside. Curr Atheroscler Rep 2003;5:150-4.
12. Cote G, Tardif JC, Lesperance J. Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group. Circulation 1999;99:30-5.
13. Weissman NJ, Sheris SJ, Chari R, et at. Intravascular ultrasonic analysis of plaque characteristics associated with coronary artery remodeling. Am J Cardiol 1999;84:37-40.
14. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987;316:1371-5.
15. Hermiller JB, Tenaglia AN, Kisslo KB, et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries. Am J Cardiol 1993;71:665-8
16. Losordo DW, Rosenfield K, Kaufman J, Pieczek A, Isner JM. Focal compensatory enlargement of human arteries in response to progressive atherosclerosis. In vivo documentation using intravascular ultrasound. Circulation 1994;89:2570-7.
17. Gerber TC, Erbel R, Gorge G, Ge J, Rupprecht HJ, Meyer J. Extent of atherosclerosis and remodeling of the left main coronary artery determined by intravascular ultrasound. Am J Cardiol 1994;73:666-71.
18. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: An intravascular ultrasound study. Circulation 2000;101:598-603.
19. Lerman A, Cannan CR, Higano SH, Nishimura RA, Holmes DR Jr. Coronary vascular remodeling in association with endothelial dysfunction. Am J Cardiol 1998;81:1105-9.
20. Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ, Leon MB. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. Circulation 1997;95:1791-8.
21. Pasterkamp G, Wensing PJ, Post MJ, Hillen B, Mali WP, Borst C. Paradoxical arterial wall shrinkage may contribute to luminal narrowing of human atherosclerotic femoral arteries. Circulation 1995;91:1444-9.
22. Pande AK, Tardif JC, Doucet S, de Guise PD, Pasternac A. Intravascular ultrasound for diagnosis of left main coronary artery stenosis. Can J Cardiol 1996;12:757-9.
23. Abizaid AS, Mintz GS, Abizaid A, et al. One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. J Am Coll Cardiol 1999;34:707-15.
24. Mintz GS, Nissen SE, Anderson WD, et al. American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001;37:1478-92.
25. Nishioka T, Amanullah AM, Luo H, et al. Clinical validation of intravascular ultrasound imaging for assessment of coronary stenosis severity: Comparison with stress myocardial perfusion imaging. J Am Coll Cardiol 1999;33:1870-8.
26. Wiedermann JG, Schwartz A, Apfelbaum M. Anatomic and physiologic heterogeneity in patients with syndrome X: An intravascular ultrasound study. J Am Coll Cardiol 1995;25:1310-7.
27. Bourassa MG, Butnaru A, Lesperance J, Tardif JC. Symptomatic myocardial bridges: Overview of ischemic mechanisms and current diagnostic and treatment strategies. J Am Coll Cardiol 2003;41:351-9.
28. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol 1994;23:352-7.
29. Hong MK, Park SW, Lee CW, et al. Intravascular ultrasound findings of negative arterial remodeling at sites of focal coronary spasm in patients with vasospastic angina. Am Heart J 2000;140:395-401.
30. Meerkin D, Tardif JC, Bertrand OF, Vincent J, Harel F, Bonan R. The effects of intracoronary brachytherapy on the natural history of postangioplasty dissections. J Am Coll Cardiol 2000;36:59-64.
31. Malekianpour M, Rodes J, Cote G, et al. Value of exercise electrocardiography in the detection of restenosis after coronary angioplasty in patients with one-vessel disease. Am J Cardiol 1999;84:258-63.
32. St Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation 1992;85:979-87.
33. Tuzcu EM, De Franco AC, Goormastic M, et al. Dichotomous pattern of coronary atherosclerosis 1 to 9 years after transplantation: Insights from systematic intravascular ultrasound imaging. J Am Coll Cardiol 1996;27:839-46.
34. Pinto FJ, Chenzbraun A, Botas J, et al. Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. Circulation 1994;90:2348-55.
35. Rickenbacher PR, Pinto FJ, Lewis NP, et al. Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 1995;92:3445-52.
36. Mehra MR, Ventura HO, Stapleton DD, Smart FW, Collins TC, Ramee SR. Presence of severe intimal thickening by intravascular ultrasonography predicts cardiac events in cardiac allograft vasculopathy. J Heart Lung Transplant 1995;14:632-9.
37. Eisen HJ, Tuzcu EM, Dorent R, et al; RAD B253 Study Group. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac,-ransplant recipients. N Engl J Med 2003;349:847-58.
38. Tuzcu EM, Hobbs RE, Rincon G, et al. Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound. Circulation 1995;91:1706-13.
39. Schartl M, Bocksch W, Koschyk DH, et al. Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. Circulation 2001;104:387-92.
40. Takagi T, Yoshida K, Akasaka T, Hozumi T, Morioka S, Yoshikawa J. Intravascular ultrasound analysis of reduction in progression of coronary narrowing by treatment with pravastatin. Am J Cardiol 1997;79:1673-6.
41. Ishikawa K, Tani S, Watanabe I, et al. Effect of pravastatin on coronary plaque volume. Am J Cardiol 2003;92:975-7.
42. Tardif JC, Gregoire J, L'Allier PL, Joyal M. Chronic heart rate reduction with ivabradine and prevention of atherosclerosis progression assessed by intravascular ultrasound. Eur Heart J 2003;5(Suppl G):G46-G51.
43. Waters D, Craven TE, Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 1993;87:1067-75.
44. Nissen SE. Rationale for a postintervention continuum of care: Insights from intravascular ultrasound. Am J Cardiol 2000;86:12H-17H.
45. Nissen SE, Tsunoda T, Tuzcu EM, et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: A randomized controlled trial. JAMA 2003;290:2292-300.
46. Tardif JC, Gregoire J, L'Allier PL, et al; Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 2004;110:3372-7.
47. Tardif JC, Gregoire J, Lesperance J, et al. Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial. Am Heart J 2002;144:589-96.
48. Barter PJ, Brewer HB Jr, Chapman MJ, Hennekens CH, Rader DJ, Tall AR. Cholesteryl ester transfer protein: A novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol 2003;23:160-7.
49. Tardif JC. Clinical results with AGI-1067: A novel antioxidant vascular protectant. Am J Cardiol 2003;91(Suppl 3A):41A-49A.
50. Tardif JC, Gregoire J, Schwartz L, et al; Canadian Antioxidant Restenosis Trial (CART-1) Investigators. Effects of AGI-1067 and probucol after percutaneous coronary interventions. Circulation 2003;107:552-8.
51. Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: Randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003;362:782-8.
52. Nissen SE, Tuzcu EM, Libby P et al; CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: The CAMELOT study: A randomized controlled trial. JAMA 2004;292:2217-25.
53. Hausmann D, Erbel R, Alibelli-Chemarin MJ, et al. The safety of intracoronary ultrasound. A multicenter survey of 2207 examinations. Circulation 1995;91:623-30.
54. Batkoff BW, Linker DT. Safety of intracoronary ultrasound: Data from a Multicenter European Registry. Cathet Cardiovasc Diagn 1996;38:238-41.
55. Pinto FJ, St Goar FG, Gao SZ, et al. Immediate and one-year safety of intracoronary ultrasonic imaging. Evaluation with serial quantitative angiography. Circulation 1993;88:1709-14.
56. Ramasubbu K, Schoenhagen P, Balghith MA, et al. Repeated intravascular ultrasound imaging in cardiac transplant recipients does not accelerate transplant coronary artery disease. J Am Coll Cardiol 2003;41:1739-43.
57. Guedes A, Keller PF, L'Allier PL, Lesperance J, Gregoire J, Tardif JC. Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. J Am Coll Cardiol 2005;45:559-64.